Neurocrine Bioscience buy Royal Bank of Canada
Start price
14.04.25
/
50%
€83.38
Target price
14.04.26
€120.31
Performance (%)
37.14%
Price
09:34
€114.35
Summary
This prediction is currently active. With a performance of 37.14% the BUY prediction by Royal_Bank_of_Canada is a big success. This prediction currently runs until 14.04.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 4.592% | 4.592% |
| iShares Core DAX® | 0.998% | 0.948% |
| iShares Nasdaq 100 | 1.965% | 4.491% |
| iShares Nikkei 225® | 4.258% | 8.018% |
| iShares S&P 500 | 2.037% | 3.420% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating. They now have a $137.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.45
31.07.25
31.07.25
€125.97
31.07.26
31.07.26
1.69%
09:34
09:34
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€108.85
02.06.25
02.06.25
€127.53
02.06.26
02.06.26
5.05%
09:34
09:34
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.90
06.05.25
06.05.25
€128.38
06.05.26
06.05.26
7.98%
09:34
09:34